慢阻肺原代支气管上皮细胞对SARS-CoV-2感染、蛋白酶及炎症反应增强的单细胞RNA测序研究
该研究对健康人与慢阻肺患者的原代支气管上皮细胞(pBECs)在接种SARS-CoV-2 7天后行单细胞RNA测序,发现慢阻肺细胞的感染量是健康细胞的24倍,Club/杯状细胞与基底细胞为主要感染群体。慢阻肺细胞中TMPRSS2、CTSB等蛋白酶升高、serpins降低,炎症细胞因子增加而IFN反应减弱;抑制蛋白酶和炎症失衡可降低病毒滴度与细胞因子反应。
要点
- 慢阻肺pBECs对SARS-CoV-2感染更易感,感染量为健康细胞的24倍。
- Club/杯状细胞与基底细胞是主要感染细胞群,表达病毒复制相关mRNA。
- 抑制蛋白酶与炎症失衡可降低病毒滴度与细胞因子反应,尤其在慢阻肺细胞中。
核心结论
- 慢阻肺pBECs因核心受体表达增加和蛋白酶失衡而对SARS-CoV-2更易感,并产生更强的炎症反应。
- 感染期间出现一群显著的IFN应答Club/杯状细胞,可能是免疫应答的重要驱动者。
- 治疗性干预可抑制SARS-CoV-2复制及随之产生的炎症。
研究设计与样本
- 对健康受试者与慢阻肺患者分化的原代支气管上皮细胞(pBECs)在接种SARS-CoV-2 7天后进行单细胞RNA测序分析。
- 将测序变化与病毒滴度、促炎反应及IFN产生进行关联分析。
主要发现
- 单细胞RNA测序显示慢阻肺pBECs感染量比健康细胞高24倍,并得到空斑试验支持。
- Club/杯状细胞和基底细胞是主要感染群体,表达参与病毒复制的mRNA。
- 参与SARS-CoV-2进入/感染的蛋白酶TMPRSS2和CTSB升高,蛋白酶抑制剂serpins在慢阻肺中下调更明显。
- 与慢阻肺急性加重和重症COVID-19相关的炎症细胞因子升高,而IFN反应减弱。
- 共表达分析发现一群高1/2型IFN反应的Club/杯状细胞,在健康与慢阻肺pBECs中均为感染免疫应答的重要驱动者。
临床怎么用
- 提示慢阻肺患者上皮屏障对SARS-CoV-2更易感,应加强疫苗接种与防护。
- 蛋白酶与炎症失衡可能是潜在干预靶点,但需进一步临床研究验证。
局限性
- 研究为体外原代支气管上皮细胞模型,不能完全反映体内复杂免疫环境。
- 样本仅来自健康受试者与慢阻肺患者,单细胞测序结果需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Patients with chronic obstructive pulmonary disease (COPD) develop more severe coronavirus disease (COVID-19); however, it is unclear whether they are more susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and what mechanisms are responsible for severe disease. Objectives: To determine whether SARS-CoV-2 inoculated primary bronchial epithelial cells (pBECs) from patients with COPD support greater infection and elucidate the effects and mechanisms involved. Methods: We performed single-cell RNA sequencing analysis on differentiated pBECs from healthy subjects and patients with COPD 7 days after SARS-CoV-2 inoculation. We correlated changes with viral titers, proinflammatory responses, and IFN production. Measurements and Main Results: Single-cell RNA sequencing revealed that COPD pBECs had 24-fold greater infection than healthy cells, which was supported by plaque assays. Club/goblet and basal cells were the predominant populations infected and expressed mRNAs involved in viral replication. Proteases involved in SARS-CoV-2 entry/infection (TMPRSS2 and CTSB) were increased, and protease inhibitors (serpins) were downregulated more so in COPD. Inflammatory cytokines linked to COPD exacerbations and severe COVID-19 were increased, whereas IFN responses were blunted. Coexpression analysis revealed a prominent population of club/goblet cells with high type 1/2 IFN responses that were important drivers of immune responses to infection in both healthy and COPD pBECs. Therapeutic inhibition of proteases and inflammatory imbalances reduced viral titers and cytokine responses, particularly in COPD pBECs. Conclusions: COPD pBECs are more susceptible to SARS-CoV-2 infection because of increases in coreceptor expression and protease imbalances and have greater inflammatory responses. A prominent cluster of IFN-responsive club/goblet cells emerges during infection, which may be important drivers of immunity. Therapeutic interventions suppress SARS-CoV-2 replication and consequent inflammation.
引用
- Johansen MD, Mahbub RM, Idrees S, et al. Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing. Am J Respir Crit Care Med. 2022. PMID: 35549656. doi:10.1164/rccm.202108-1901OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。